According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, 1% market achieved annual sales of approximately $5.8 million.
MAHWAH, N.J. – Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of clindamycin phosphate foam, 1%. Glenmark's clindamycin phosphate foam, 1% is bioequivalent and therapeutically equivalent to the reference listed drug, Evoclin Foam, 1%, of Mylan Pharmaceuticals Inc.
According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, 1% market achieved annual sales of approximately $5.8 million.
Move to drive the launch of RedSail Pay, a comprehensive Merchant services solution.
The FDA has yet to comment on how it will proceed. Eli Lilly could pursue legal action against compounding pharmacies.
For the second consecutive year, McKesson collaborated with organizations such as Genentech, Kenvue, and the Leukemia & Lymphoma Society to educate more than 2,300 Navajo Nation members on cancer, diabetes, and nutrition.
“CHPA commends Mississippi for taking decisive action today to ensure the NPLEx system remains a powerful tool in stopping illegal sales,” said Carlos Gutierrez.
Move to drive the launch of RedSail Pay, a comprehensive Merchant services solution.
The Super Savings Week runs online from March 24 to April 1, offering great deals across top categories.
The FDA has yet to comment on how it will proceed. Eli Lilly could pursue legal action against compounding pharmacies.
For the second consecutive year, McKesson collaborated with organizations such as Genentech, Kenvue, and the Leukemia & Lymphoma Society to educate more than 2,300 Navajo Nation members on cancer, diabetes, and nutrition.
